Home
|
Press
|
Events
|
Eshare
Sign in
/
Register
0
Shopping Cart
X
Close
My Products (0 items)
My shopping cart is empty.
.
Sign in
/
Register
X
Close
Login/Register
Email
Password
INDUSTRIES
Agriculture
Chemicals
Food & Feed
Pesticides
Titanium Dioxide (TiO2)
Dairy Products
Full Industry List
ONLINE DATABASE
PRODUCTS & SERVICE
Products' Introduction
Industrial Reports
Newsletters
Market Data
Content Byte
Agrochemical Regulatory
Customized solutions
IMPACT FACTOR
MARKET NEWS
Agriculture
Chemicals
Food & Feed
Other
ABOUT
About CCM
Why CCM?
CCM Story
CCM Clients
Events
Career
Company news
CONTACT
Home
Product
Newsletters
>
和邦生物:估计2022年双甘膦业绩不比2021年佳
Read online
和邦生物:估计2022年双甘膦业绩不比2021年佳
摘要:和邦生物的双甘膦2022年出口预计接近20,772吨。与2021年相比,其双甘膦出口量有所下降。这主要是由于2022年草甘膦原药的市场需求低迷所致。和邦生物认为,2023年草甘膦原药的市场将会比2022年旺盛。为更大发展其双甘膦业务,和邦生物已在2022年9月由其下属子公司广安必美达投建50万吨年产能的双甘膦生产线。该项目已在建设当中,并将于2024年投产运营。据西美信息2023年1月中旬监测,四川和邦生物科技股份有限公司(简称"和邦生物")的双甘膦2022年出口预计接近20,772吨。与...
Glyphosate China Monthly Report (Chinese version) 202301
Add to DIY report
Select whole article
I haven't create reports,
create a new report
right now!
Recommend Newsletters
Crop Farming in China
2016/05/31
More>>
Report on Glyphosate Business Opportunities Worldwide
2016/07/27
More>>
Specialised Control and Prevention of Pests and Diseases for Crops in China
2016/07/12
More>>
Loading...